PRESS RELEASE: Michael Aldridge, Seasoned Biotech Executive, Appointed CEO of Focal Medical | Company Launches Corporate Rebranding
RALEIGH, N.C. (November 1, 2022): Focal Medical, Inc. (formerly Advanced Chemotherapy Technologies, Inc.), a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative local drug delivery technology platform, today announced the appointment of Michael Aldridge as the Company’s…